SHOX2

short stature homeobox 2, the group of PRD class homeoboxes and pseudogenes

Basic information

Region (hg38): 3:158095905-158106420

Links

ENSG00000168779NCBI:6474OMIM:602504HGNC:10854Uniprot:O60902AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • schizophrenia (No Known Disease Relationship), mode of inheritance: Unknown

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SHOX2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SHOX2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
5
clinvar
1
clinvar
8
missense
27
clinvar
2
clinvar
29
nonsense
0
start loss
0
frameshift
0
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 29 8 1

Variants in SHOX2

This is a list of pathogenic ClinVar variants found in the SHOX2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-158098110-C-A not specified Uncertain significance (Dec 12, 2023)3161871
3-158098130-G-C not specified Uncertain significance (Feb 15, 2023)2468084
3-158098135-G-C Likely benign (Mar 01, 2023)2654254
3-158098148-T-C not specified Uncertain significance (Apr 08, 2023)2535471
3-158098196-A-G not specified Uncertain significance (Dec 15, 2023)3161870
3-158098211-T-C not specified Uncertain significance (Jun 27, 2022)2298080
3-158098221-G-C not specified Uncertain significance (Apr 18, 2023)2537474
3-158098227-G-T not specified Uncertain significance (Jun 26, 2023)2606545
3-158098230-G-A not specified Uncertain significance (Nov 17, 2022)2278632
3-158098308-T-G not specified Uncertain significance (Apr 12, 2024)3318339
3-158099931-C-T not specified Uncertain significance (Dec 19, 2023)3161869
3-158099932-G-A Benign (Dec 13, 2018)780108
3-158099940-T-G not specified Uncertain significance (Dec 28, 2022)2340107
3-158100311-C-T not specified Uncertain significance (Mar 24, 2023)2519852
3-158100317-G-C SHOX2-related disorder Likely benign (Oct 04, 2019)3045746
3-158102696-C-A SHOX2-related disorder Likely benign (Apr 01, 2019)3058527
3-158102837-G-C not specified Uncertain significance (Apr 29, 2024)3318340
3-158102878-C-T not specified Uncertain significance (Aug 08, 2023)2616833
3-158105069-A-C not specified Uncertain significance (Jul 13, 2022)2408988
3-158105089-C-T Uncertain significance (Jan 28, 2015)195193
3-158105682-C-T not specified Uncertain significance (Mar 31, 2022)2221382
3-158105714-C-G not specified Uncertain significance (Feb 15, 2023)2466545
3-158105719-G-C SHOX2-related disorder Likely benign (Apr 08, 2019)3046370
3-158105721-C-T Uncertain significance (Jan 01, 2020)872139
3-158105730-T-A Uncertain significance (Aug 21, 2015)282228

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SHOX2protein_codingprotein_codingENST00000389589 69345
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.01610.962125741061257470.0000239
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.09981961921.020.000008792243
Missense in Polyphen7292.7330.776421106
Synonymous-1.3810487.61.190.00000430758
Loss of Function1.99512.70.3955.67e-7159

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001280.000123
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001830.0000176
Middle Eastern0.000.00
South Asian0.00003280.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: May be a growth regulator and have a role in specifying neural systems involved in processing somatosensory information, as well as in face and body structure formation.;

Recessive Scores

pRec
0.130

Intolerance Scores

loftool
0.127
rvis_EVS
-0.41
rvis_percentile_EVS
26.23

Haploinsufficiency Scores

pHI
0.831
hipred
Y
hipred_score
0.711
ghis
0.575

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.955

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Shox2
Phenotype
craniofacial phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; digestive/alimentary phenotype; skeleton phenotype;

Zebrafish Information Network

Gene name
shox2
Affected structure
sinus venosus
Phenotype tag
abnormal
Phenotype quality
hypoplastic

Gene ontology

Biological process
skeletal system development;osteoblast differentiation;positive regulation of mesenchymal cell proliferation;chondrocyte development;heart valve development;cardiac atrium morphogenesis;regulation of transcription by RNA polymerase II;nervous system development;heart development;regulation of chondrocyte differentiation;embryonic forelimb morphogenesis;positive regulation of smoothened signaling pathway;embryonic digestive tract morphogenesis;positive regulation of skeletal muscle fiber development;positive regulation of axonogenesis;embryonic skeletal joint morphogenesis;cartilage development involved in endochondral bone morphogenesis;muscle tissue morphogenesis;regulation of branching morphogenesis of a nerve
Cellular component
nucleus
Molecular function
DNA-binding transcription factor activity, RNA polymerase II-specific;sequence-specific DNA binding